BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16714457)

  • 1. Evaluation of a prospective scoring system designed for a multicenter breast MR imaging screening study.
    Warren RM; Thompson D; Pointon LJ; Hoff R; Gilbert FJ; Padhani AR; Easton DF; Lakhani SR; Leach MO;
    Radiology; 2006 Jun; 239(3):677-85. PubMed ID: 16714457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
    Schnall MD; Blume J; Bluemke DA; DeAngelis GA; DeBruhl N; Harms S; Heywang-Köbrunner SH; Hylton N; Kuhl CK; Pisano ED; Causer P; Schnitt SJ; Thickman D; Stelling CB; Weatherall PT; Lehman C; Gatsonis CA
    Radiology; 2006 Jan; 238(1):42-53. PubMed ID: 16373758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience.
    Kuhl CK; Jost P; Morakkabati N; Zivanovic O; Schild HH; Gieseke J
    Radiology; 2006 Jun; 239(3):666-76. PubMed ID: 16549623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
    Kuhl CK; Schild HH; Morakkabati N
    Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system.
    Jung JA; Coakley FV; Vigneron DB; Swanson MG; Qayyum A; Weinberg V; Jones KD; Carroll PR; Kurhanewicz J
    Radiology; 2004 Dec; 233(3):701-8. PubMed ID: 15564406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of a dedicated 1.5-T breast MR imaging system.
    Hillman BJ; Harms SE; Stevens G; Stough RG; Hollingsworth AB; Kozlowski KF; Moss LJ
    Radiology; 2012 Oct; 265(1):51-8. PubMed ID: 22923716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced breast MR imaging in men: preliminary results.
    Morakkabati-Spitz N; Schild HH; Leutner CC; von Falkenhausen M; Lutterbey G; Kuhl CK
    Radiology; 2006 Feb; 238(2):438-45. PubMed ID: 16371581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy.
    van Rijswijk CS; Geirnaerdt MJ; Hogendoorn PC; Taminiau AH; van Coevorden F; Zwinderman AH; Pope TL; Bloem JL
    Radiology; 2004 Nov; 233(2):493-502. PubMed ID: 15459325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability.
    Kinkel K; Helbich TH; Esserman LJ; Barclay J; Schwerin EH; Sickles EA; Hylton NM
    AJR Am J Roentgenol; 2000 Jul; 175(1):35-43. PubMed ID: 10882243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adnexal masses: development and preliminary validation of an MR imaging scoring system.
    Thomassin-Naggara I; Aubert E; Rockall A; Jalaguier-Coudray A; Rouzier R; Daraï E; Bazot M
    Radiology; 2013 May; 267(2):432-43. PubMed ID: 23468574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
    Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
    Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the Accuracy of Computer-aided Diagnosis for Breast MR Imaging by Differentiating between Mass and Nonmass Lesions.
    Gallego-Ortiz C; Martel AL
    Radiology; 2016 Mar; 278(3):679-88. PubMed ID: 26383229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Readout-segmented echo-planar imaging improves the diagnostic performance of diffusion-weighted MR breast examinations at 3.0 T.
    Bogner W; Pinker-Domenig K; Bickel H; Chmelik M; Weber M; Helbich TH; Trattnig S; Gruber S
    Radiology; 2012 Apr; 263(1):64-76. PubMed ID: 22438442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of clinical breast MR imaging performed with prototype computer-aided diagnosis breast MR imaging workstation: reader study.
    Shimauchi A; Giger ML; Bhooshan N; Lan L; Pesce LL; Lee JK; Abe H; Newstead GM
    Radiology; 2011 Mar; 258(3):696-704. PubMed ID: 21212365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of breast mass lesions using model-based analysis of the characteristic kinetic curve derived from fuzzy c-means clustering.
    Chang YC; Huang YH; Huang CS; Chang PK; Chen JH; Chang RF
    Magn Reson Imaging; 2012 Apr; 30(3):312-22. PubMed ID: 22245697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T2-weighted MR imaging in the assessment of cirrhotic liver.
    Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
    Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.
    Parikh T; Drew SJ; Lee VS; Wong S; Hecht EM; Babb JS; Taouli B
    Radiology; 2008 Mar; 246(3):812-22. PubMed ID: 18223123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
    Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
    Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.